In the meantime, NEAT1 knockdown has decreased the NAFLD through the mTOR/S6K1 pathway, which modulates protein and lipid biosynthesis and remit NAFLD. The gene discussed is RPS6KB1; the disease is metabolic dysfunction-associated steatotic liver disease.